Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiabing Zhan

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Signal Transduction and Targeted Therapy|February 18, 2021
The double face of miR-320: cardiomyocytes-derived miR-320 deteriorated while fibroblasts-derived miR-320 protected against heart failure induced by transverse aortic constrictionXudong Zhang, Shuai Yuan, Huaping Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2024
Nuclear AGO2 promotes myocardial remodeling by activating ANKRD1 transcription in failing heartsRong Xie, Shuai Yuan, Guo Hu, et al.
Molecular Therapy. Nucleic Acids|May 22, 2023
LncRNA ZNF593-AS alleviates diabetic cardiomyopathy via suppressing IRF3 signaling pathwayRong Xie, Jiahui Fan, Jianpei Wen, et al.
Science China. Life Sciences|May 29, 2024
Fibroblast-localized lncRNA CFIRL promotes cardiac fibrosis and dysfunction in dilated cardiomyopathyShuai Yuan, Xudong Zhang, Jiabing Zhan, et al.
Molecular Therapy. Nucleic Acids|March 7, 2022
Overexpression of cytosolic long noncoding RNA cytb protects against pressure-overload-induced heart failure via sponging microRNA-103-3pXudong Zhang, Shuai Yuan, Jingbo Liu, et al.
Circulation Research|February 8, 2021
LncRNA ZNF593-AS Alleviates Contractile Dysfunction in Dilated CardiomyopathyJiahui Fan, Huaping Li, Rong Xie, et al.
European Heart Journal|March 5, 2026
Nuclear AGO2 exacerbates heart failure with preserved ejection fraction through myocardial ketogenesisKunying Jin, Yuyan Tang, Jiabing Zhan, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Signal Transduction and Targeted Therapy|February 18, 2021
The double face of miR-320: cardiomyocytes-derived miR-320 deteriorated while fibroblasts-derived miR-320 protected against heart failure induced by transverse aortic constrictionXudong Zhang, Shuai Yuan, Huaping Li, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 13, 2024
Nuclear AGO2 promotes myocardial remodeling by activating ANKRD1 transcription in failing heartsRong Xie, Shuai Yuan, Guo Hu, et al.
Molecular Therapy. Nucleic Acids|May 22, 2023
LncRNA ZNF593-AS alleviates diabetic cardiomyopathy via suppressing IRF3 signaling pathwayRong Xie, Jiahui Fan, Jianpei Wen, et al.
Science China. Life Sciences|May 29, 2024
Fibroblast-localized lncRNA CFIRL promotes cardiac fibrosis and dysfunction in dilated cardiomyopathyShuai Yuan, Xudong Zhang, Jiabing Zhan, et al.
Molecular Therapy. Nucleic Acids|March 7, 2022
Overexpression of cytosolic long noncoding RNA cytb protects against pressure-overload-induced heart failure via sponging microRNA-103-3pXudong Zhang, Shuai Yuan, Jingbo Liu, et al.
Circulation Research|February 8, 2021
LncRNA ZNF593-AS Alleviates Contractile Dysfunction in Dilated CardiomyopathyJiahui Fan, Huaping Li, Rong Xie, et al.
European Heart Journal|March 5, 2026
Nuclear AGO2 exacerbates heart failure with preserved ejection fraction through myocardial ketogenesisKunying Jin, Yuyan Tang, Jiabing Zhan, et al.
Pageof 2